Cargando…

Case Report: THSD7A-Positive Membranous Nephropathy Caused by Tislelizumab in a Lung Cancer Patient

Immune checkpoint inhibitors (ICIs) became the standard treatment for many different kinds of cancers and can result in a variety of immune-related adverse events (irAEs). IrAEs of kidney are uncommon and consists of different pathology types. Among the different types, membranous nephropathy (MN) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Minjiang, Zhang, Lei, Zhong, Wei, Zheng, Ke, Ye, Wei, Wang, Mengzhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141750/ https://www.ncbi.nlm.nih.gov/pubmed/34040602 http://dx.doi.org/10.3389/fimmu.2021.619147

Ejemplares similares

Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy
por: Reinhard, Linda, et al.
Publicado: (2021)

A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy
por: Wanderley, David Campos, et al.
Publicado: (2019)

The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy
por: Manral, Pallavi, et al.
Publicado: (2022)

Meta‐Analysis of the Diagnostic Efficiency of THSD7A‐AB for the Diagnosis of Idiopathic Membranous Nephropathy
por: Liu, Yipeng, et al.
Publicado: (2020)

An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN
por: Ren, Song, et al.
Publicado: (2018)

A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy
por: Zhang, Pingna, et al.
Publicado: (2021)

Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia
por: Shirai, Sayuri, et al.
Publicado: (2019)

Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: a clinicopathological study
por: Sharma, Shree G, et al.
Publicado: (2018)

Thrombospondin Type 1 Domain-Containing 7A (THSD7A)-Associated Membranous Nephropathy Leading to Metastatic Neuroendocrine Carcinoma
por: Juarez, Angel, et al.
Publicado: (2023)

THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity
por: Larsen, Christopher P, et al.
Publicado: (2016)

Expression of THSD7A in neoplasm tissues and its relationship with proteinuria
por: Xian, Li, et al.
Publicado: (2019)

THSD7A Positivity Is Associated with High Expression of FAK in Prostate Cancer
por: Flockerzi, Fidelis Andrea, et al.
Publicado: (2023)

Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain
por: Fresquet, M., et al.
Publicado: (2020)

Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans
por: Lwezaula, Bingileki F, et al.
Publicado: (2021)

Case Report: Life-threatening pancytopenia with tislelizumab followed by cerebral infarction in a patient with lung adenocarcinoma
por: Gu, Hang-Yu, et al.
Publicado: (2023)

Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers
por: Zheng, Xiaojing, et al.
Publicado: (2023)

THSD7B Mutation Induces Platinum Resistance in Small Cell Lung Cancer Patients
por: Yao, Zifu, et al.
Publicado: (2022)

Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer
por: Liang, Hongge, et al.
Publicado: (2022)

The Role of Anti-PLA(2)R and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice
por: Smarz-Widelska, Iwona, et al.
Publicado: (2022)

Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer
por: Miao, Kang, et al.
Publicado: (2022)

Corrigendum: Peripheral blood lymphocyte subsets predict the efficacy of immune checkpoint inhibitors in non– small cell lung cancer
por: Miao, Kang, et al.
Publicado: (2022)

Histological transition from minimal change disease to THSD7A-associated membranous nephropathy in a patient receiving long-term steroid treatment: A case report
por: Kojima, Aki, et al.
Publicado: (2023)

Identification of THSD7B and PRMT9 mutations as risk factors for familial lung adenocarcinoma: A case report
por: Zhang, Qianqian, et al.
Publicado: (2023)

Case Report: Successful Management of a Refractory Plasmablastic Lymphoma Patient With Tislelizumab and Lenalidomide
por: Cheng, Lili, et al.
Publicado: (2021)

Soluble THSD7A Is an N-Glycoprotein That Promotes Endothelial Cell Migration and Tube Formation in Angiogenesis
por: Kuo, Meng-Wei, et al.
Publicado: (2011)

Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity
por: Liu, Wenbin, et al.
Publicado: (2020)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
por: He, Jia-Wei, et al.
Publicado: (2022)

Role of Serum and Urine Biomarkers (PLA(2)R and THSD7A) in Diagnosis, Monitoring and Prognostication of Primary Membranous Glomerulonephritis
por: Maifata, Sadiq Mu’azu, et al.
Publicado: (2020)

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2022)

Concurrent Driver Gene Mutations as Negative Predictive Factors in Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer
por: Chen, Minjiang, et al.
Publicado: (2019)

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?
por: He, Jia-Wei, et al.
Publicado: (2023)

Pathological complete response to neoadjuvant tislelizumab plus chemotherapy in stage IIIB small cell lung cancer: A case report and literature review
por: Zhou, Nan, et al.
Publicado: (2023)

The Landscape and Prognosis Potential of the T-Cell Repertoire in Membranous Nephropathy
por: Zhang, Yu, et al.
Publicado: (2020)

THSD7A Positivity Predicts Poor Survival and Is Linked to High FAK Expression and FGFR1-Wildtype in Female Patients with Squamous Cell Carcinoma of the Lung
por: Flockerzi, Fidelis Andrea, et al.
Publicado: (2023)

Expression, prognosis and functional role of Thsd7a in esophageal squamous cell carcinoma of Kazakh patients, Xinjiang
por: Hou, Zhichao, et al.
Publicado: (2017)

Positive tumour CD47 expression is an independent prognostic factor for recurrence in resected non-small cell lung cancer
por: Xu, Yan, et al.
Publicado: (2020)

The Diagnostic and Prognostic Potential of the B-Cell Repertoire in Membranous Nephropathy
por: Su, Zuhui, et al.
Publicado: (2021)

ALK‐rearranged lung cancer with intradural extramedullary spinal cord metastases responding to ceritinib treatment: A case report
por: Xu, Yan, et al.
Publicado: (2018)

Novel Biomarkers in Membranous Nephropathy
por: Liu, Qiuying, et al.
Publicado: (2022)

Editorial: Primary membranous nephropathy
por: Infantino, Maria
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g560sumq7vo0cq2osjrrjp2i4u